published meta-analysis   sensitivity analysis   studies

Vitamin D in COVID-19 severe or critically - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsCOVID-VIT-D, 2022 1.48 [0.75; 2.92] 1.48[0.75; 2.92]COVID-VIT-D, 202210%543NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-05-03 08:56 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 91 - treatments: 734,1439 - roots T: 290